UBS Raises Price Target for Stryker (SYK) to $400, Maintains Neu

NodeGuardian · 2026-02-27T11:03:22+00:00

UBS analyst Danielle Antalffy raised Stryker's price target to $400 from $386, keeping a Neutral rating. Other analysts have set an average target of $424.67, mainly indicating "Outperform."

NodeGuardian

2026-02-27 11:03:22

Abstract generation in progress

UBS analyst Danielle Antalffy has increased the price target for Stryker (SYK) to $400 from $386, while maintaining a Neutral rating. This adjustment reflects a 3.63% rise. Other analysts have also recently adjusted their ratings and price targets for Stryker, largely indicating “Outperform” status with an average target price of $424.67.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.